0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biotech Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-2O14129
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biotech Drug Market Research Report 2023
BUY CHAPTERS

Global Biotech Drug Market Research Report 2025

Code: QYRE-Auto-2O14129
Report
May 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biotech Drug Market Size

The global market for Biotech Drug was valued at US$ 441320 million in the year 2024 and is projected to reach a revised size of US$ 784010 million by 2031, growing at a CAGR of 8.7% during the forecast period.

Biotech Drug Market

Biotech Drug Market

Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biotech Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotech Drug.
The Biotech Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biotech Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biotech Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biotech Drug Market Report

Report Metric Details
Report Name Biotech Drug Market
Accounted market size in year US$ 441320 million
Forecasted market size in 2031 US$ 784010 million
CAGR 8.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Biogen, Celltrion, Sobi, 3SBIO, Changchun High Tech, Kanghong Pharma, Innovent Biologics, Gan&Lee, Tonghua Dongbao, United Laboratory
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biotech Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biotech Drug Market growing?

Ans: The Biotech Drug Market witnessing a CAGR of 8.7% during the forecast period 2025-2031.

What is the Biotech Drug Market size in 2031?

Ans: The Biotech Drug Market size in 2031 will be US$ 784010 million.

Who are the main players in the Biotech Drug Market report?

Ans: The main players in the Biotech Drug Market are Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Biogen, Celltrion, Sobi, 3SBIO, Changchun High Tech, Kanghong Pharma, Innovent Biologics, Gan&Lee, Tonghua Dongbao, United Laboratory

What are the Application segmentation covered in the Biotech Drug Market report?

Ans: The Applications covered in the Biotech Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Biotech Drug Market report?

Ans: The Types covered in the Biotech Drug Market report are Monoclonal Antibodies, Interferon, Insulin, Vaccines, Others

Recommended Reports

Drug Markets

Diagnostics & Testing

Biotech & Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotech Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Insulin
1.2.5 Vaccines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biotech Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biotech Drug Market Perspective (2020-2031)
2.2 Global Biotech Drug Growth Trends by Region
2.2.1 Global Biotech Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biotech Drug Historic Market Size by Region (2020-2025)
2.2.3 Biotech Drug Forecasted Market Size by Region (2026-2031)
2.3 Biotech Drug Market Dynamics
2.3.1 Biotech Drug Industry Trends
2.3.2 Biotech Drug Market Drivers
2.3.3 Biotech Drug Market Challenges
2.3.4 Biotech Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biotech Drug Players by Revenue
3.1.1 Global Top Biotech Drug Players by Revenue (2020-2025)
3.1.2 Global Biotech Drug Revenue Market Share by Players (2020-2025)
3.2 Global Biotech Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biotech Drug Revenue
3.4 Global Biotech Drug Market Concentration Ratio
3.4.1 Global Biotech Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotech Drug Revenue in 2024
3.5 Global Key Players of Biotech Drug Head office and Area Served
3.6 Global Key Players of Biotech Drug, Product and Application
3.7 Global Key Players of Biotech Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biotech Drug Breakdown Data by Type
4.1 Global Biotech Drug Historic Market Size by Type (2020-2025)
4.2 Global Biotech Drug Forecasted Market Size by Type (2026-2031)
5 Biotech Drug Breakdown Data by Application
5.1 Global Biotech Drug Historic Market Size by Application (2020-2025)
5.2 Global Biotech Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biotech Drug Market Size (2020-2031)
6.2 North America Biotech Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biotech Drug Market Size by Country (2020-2025)
6.4 North America Biotech Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biotech Drug Market Size (2020-2031)
7.2 Europe Biotech Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biotech Drug Market Size by Country (2020-2025)
7.4 Europe Biotech Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biotech Drug Market Size (2020-2031)
8.2 Asia-Pacific Biotech Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biotech Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Biotech Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biotech Drug Market Size (2020-2031)
9.2 Latin America Biotech Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biotech Drug Market Size by Country (2020-2025)
9.4 Latin America Biotech Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biotech Drug Market Size (2020-2031)
10.2 Middle East & Africa Biotech Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biotech Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Biotech Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Biotech Drug Introduction
11.1.4 Roche Revenue in Biotech Drug Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Biotech Drug Introduction
11.2.4 Amgen Revenue in Biotech Drug Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biotech Drug Introduction
11.3.4 AbbVie Revenue in Biotech Drug Business (2020-2025)
11.3.5 AbbVie Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Biotech Drug Introduction
11.4.4 Sanofi Revenue in Biotech Drug Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Biotech Drug Introduction
11.5.4 Johnson & Johnson Revenue in Biotech Drug Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biotech Drug Introduction
11.6.4 Pfizer Revenue in Biotech Drug Business (2020-2025)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biotech Drug Introduction
11.7.4 Novo Nordisk Revenue in Biotech Drug Business (2020-2025)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biotech Drug Introduction
11.8.4 Eli Lilly Revenue in Biotech Drug Business (2020-2025)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Biotech Drug Introduction
11.9.4 Novartis Revenue in Biotech Drug Business (2020-2025)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biotech Drug Introduction
11.10.4 Merck Revenue in Biotech Drug Business (2020-2025)
11.10.5 Merck Recent Development
11.11 Biogen
11.11.1 Biogen Company Details
11.11.2 Biogen Business Overview
11.11.3 Biogen Biotech Drug Introduction
11.11.4 Biogen Revenue in Biotech Drug Business (2020-2025)
11.11.5 Biogen Recent Development
11.12 Celltrion
11.12.1 Celltrion Company Details
11.12.2 Celltrion Business Overview
11.12.3 Celltrion Biotech Drug Introduction
11.12.4 Celltrion Revenue in Biotech Drug Business (2020-2025)
11.12.5 Celltrion Recent Development
11.13 Sobi
11.13.1 Sobi Company Details
11.13.2 Sobi Business Overview
11.13.3 Sobi Biotech Drug Introduction
11.13.4 Sobi Revenue in Biotech Drug Business (2020-2025)
11.13.5 Sobi Recent Development
11.14 3SBIO
11.14.1 3SBIO Company Details
11.14.2 3SBIO Business Overview
11.14.3 3SBIO Biotech Drug Introduction
11.14.4 3SBIO Revenue in Biotech Drug Business (2020-2025)
11.14.5 3SBIO Recent Development
11.15 Changchun High Tech
11.15.1 Changchun High Tech Company Details
11.15.2 Changchun High Tech Business Overview
11.15.3 Changchun High Tech Biotech Drug Introduction
11.15.4 Changchun High Tech Revenue in Biotech Drug Business (2020-2025)
11.15.5 Changchun High Tech Recent Development
11.16 Kanghong Pharma
11.16.1 Kanghong Pharma Company Details
11.16.2 Kanghong Pharma Business Overview
11.16.3 Kanghong Pharma Biotech Drug Introduction
11.16.4 Kanghong Pharma Revenue in Biotech Drug Business (2020-2025)
11.16.5 Kanghong Pharma Recent Development
11.17 Innovent Biologics
11.17.1 Innovent Biologics Company Details
11.17.2 Innovent Biologics Business Overview
11.17.3 Innovent Biologics Biotech Drug Introduction
11.17.4 Innovent Biologics Revenue in Biotech Drug Business (2020-2025)
11.17.5 Innovent Biologics Recent Development
11.18 Gan&Lee
11.18.1 Gan&Lee Company Details
11.18.2 Gan&Lee Business Overview
11.18.3 Gan&Lee Biotech Drug Introduction
11.18.4 Gan&Lee Revenue in Biotech Drug Business (2020-2025)
11.18.5 Gan&Lee Recent Development
11.19 Tonghua Dongbao
11.19.1 Tonghua Dongbao Company Details
11.19.2 Tonghua Dongbao Business Overview
11.19.3 Tonghua Dongbao Biotech Drug Introduction
11.19.4 Tonghua Dongbao Revenue in Biotech Drug Business (2020-2025)
11.19.5 Tonghua Dongbao Recent Development
11.20 United Laboratory
11.20.1 United Laboratory Company Details
11.20.2 United Laboratory Business Overview
11.20.3 United Laboratory Biotech Drug Introduction
11.20.4 United Laboratory Revenue in Biotech Drug Business (2020-2025)
11.20.5 United Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Biotech Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Interferon
 Table 4. Key Players of Insulin
 Table 5. Key Players of Vaccines
 Table 6. Key Players of Others
 Table 7. Global Biotech Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Biotech Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Biotech Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Biotech Drug Market Share by Region (2020-2025)
 Table 11. Global Biotech Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Biotech Drug Market Share by Region (2026-2031)
 Table 13. Biotech Drug Market Trends
 Table 14. Biotech Drug Market Drivers
 Table 15. Biotech Drug Market Challenges
 Table 16. Biotech Drug Market Restraints
 Table 17. Global Biotech Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Biotech Drug Market Share by Players (2020-2025)
 Table 19. Global Top Biotech Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotech Drug as of 2024)
 Table 20. Ranking of Global Top Biotech Drug Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Biotech Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Biotech Drug, Headquarters and Area Served
 Table 23. Global Key Players of Biotech Drug, Product and Application
 Table 24. Global Key Players of Biotech Drug, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Biotech Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Biotech Drug Revenue Market Share by Type (2020-2025)
 Table 28. Global Biotech Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Biotech Drug Revenue Market Share by Type (2026-2031)
 Table 30. Global Biotech Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Biotech Drug Revenue Market Share by Application (2020-2025)
 Table 32. Global Biotech Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Biotech Drug Revenue Market Share by Application (2026-2031)
 Table 34. North America Biotech Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Biotech Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Biotech Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Biotech Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Biotech Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Biotech Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Biotech Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Biotech Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Biotech Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Biotech Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Biotech Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Biotech Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Biotech Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Biotech Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Biotech Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Roche Company Details
 Table 50. Roche Business Overview
 Table 51. Roche Biotech Drug Product
 Table 52. Roche Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 53. Roche Recent Development
 Table 54. Amgen Company Details
 Table 55. Amgen Business Overview
 Table 56. Amgen Biotech Drug Product
 Table 57. Amgen Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 58. Amgen Recent Development
 Table 59. AbbVie Company Details
 Table 60. AbbVie Business Overview
 Table 61. AbbVie Biotech Drug Product
 Table 62. AbbVie Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 63. AbbVie Recent Development
 Table 64. Sanofi Company Details
 Table 65. Sanofi Business Overview
 Table 66. Sanofi Biotech Drug Product
 Table 67. Sanofi Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 68. Sanofi Recent Development
 Table 69. Johnson & Johnson Company Details
 Table 70. Johnson & Johnson Business Overview
 Table 71. Johnson & Johnson Biotech Drug Product
 Table 72. Johnson & Johnson Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 73. Johnson & Johnson Recent Development
 Table 74. Pfizer Company Details
 Table 75. Pfizer Business Overview
 Table 76. Pfizer Biotech Drug Product
 Table 77. Pfizer Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 78. Pfizer Recent Development
 Table 79. Novo Nordisk Company Details
 Table 80. Novo Nordisk Business Overview
 Table 81. Novo Nordisk Biotech Drug Product
 Table 82. Novo Nordisk Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 83. Novo Nordisk Recent Development
 Table 84. Eli Lilly Company Details
 Table 85. Eli Lilly Business Overview
 Table 86. Eli Lilly Biotech Drug Product
 Table 87. Eli Lilly Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 88. Eli Lilly Recent Development
 Table 89. Novartis Company Details
 Table 90. Novartis Business Overview
 Table 91. Novartis Biotech Drug Product
 Table 92. Novartis Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 93. Novartis Recent Development
 Table 94. Merck Company Details
 Table 95. Merck Business Overview
 Table 96. Merck Biotech Drug Product
 Table 97. Merck Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 98. Merck Recent Development
 Table 99. Biogen Company Details
 Table 100. Biogen Business Overview
 Table 101. Biogen Biotech Drug Product
 Table 102. Biogen Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 103. Biogen Recent Development
 Table 104. Celltrion Company Details
 Table 105. Celltrion Business Overview
 Table 106. Celltrion Biotech Drug Product
 Table 107. Celltrion Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 108. Celltrion Recent Development
 Table 109. Sobi Company Details
 Table 110. Sobi Business Overview
 Table 111. Sobi Biotech Drug Product
 Table 112. Sobi Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 113. Sobi Recent Development
 Table 114. 3SBIO Company Details
 Table 115. 3SBIO Business Overview
 Table 116. 3SBIO Biotech Drug Product
 Table 117. 3SBIO Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 118. 3SBIO Recent Development
 Table 119. Changchun High Tech Company Details
 Table 120. Changchun High Tech Business Overview
 Table 121. Changchun High Tech Biotech Drug Product
 Table 122. Changchun High Tech Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 123. Changchun High Tech Recent Development
 Table 124. Kanghong Pharma Company Details
 Table 125. Kanghong Pharma Business Overview
 Table 126. Kanghong Pharma Biotech Drug Product
 Table 127. Kanghong Pharma Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 128. Kanghong Pharma Recent Development
 Table 129. Innovent Biologics Company Details
 Table 130. Innovent Biologics Business Overview
 Table 131. Innovent Biologics Biotech Drug Product
 Table 132. Innovent Biologics Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 133. Innovent Biologics Recent Development
 Table 134. Gan&Lee Company Details
 Table 135. Gan&Lee Business Overview
 Table 136. Gan&Lee Biotech Drug Product
 Table 137. Gan&Lee Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 138. Gan&Lee Recent Development
 Table 139. Tonghua Dongbao Company Details
 Table 140. Tonghua Dongbao Business Overview
 Table 141. Tonghua Dongbao Biotech Drug Product
 Table 142. Tonghua Dongbao Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 143. Tonghua Dongbao Recent Development
 Table 144. United Laboratory Company Details
 Table 145. United Laboratory Business Overview
 Table 146. United Laboratory Biotech Drug Product
 Table 147. United Laboratory Revenue in Biotech Drug Business (2020-2025) & (US$ Million)
 Table 148. United Laboratory Recent Development
 Table 149. Research Programs/Design for This Report
 Table 150. Key Data Information from Secondary Sources
 Table 151. Key Data Information from Primary Sources
 Table 152. Authors List of This Report


List of Figures
 Figure 1. Biotech Drug Picture
 Figure 2. Global Biotech Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biotech Drug Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Interferon Features
 Figure 6. Insulin Features
 Figure 7. Vaccines Features
 Figure 8. Others Features
 Figure 9. Global Biotech Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Biotech Drug Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Case Studies
 Figure 12. Retail Pharmacy Case Studies
 Figure 13. Other Case Studies
 Figure 14. Biotech Drug Report Years Considered
 Figure 15. Global Biotech Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Biotech Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Biotech Drug Market Share by Region: 2024 VS 2031
 Figure 18. Global Biotech Drug Market Share by Players in 2024
 Figure 19. Global Top Biotech Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotech Drug as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Biotech Drug Revenue in 2024
 Figure 21. North America Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Biotech Drug Market Share by Country (2020-2031)
 Figure 23. United States Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Biotech Drug Market Share by Country (2020-2031)
 Figure 27. Germany Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Biotech Drug Market Share by Region (2020-2031)
 Figure 35. China Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Biotech Drug Market Share by Country (2020-2031)
 Figure 43. Mexico Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Biotech Drug Market Share by Country (2020-2031)
 Figure 47. Turkey Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Biotech Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Roche Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 51. Amgen Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 52. AbbVie Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 53. Sanofi Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 54. Johnson & Johnson Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 55. Pfizer Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 56. Novo Nordisk Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 57. Eli Lilly Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 58. Novartis Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 59. Merck Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 60. Biogen Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 61. Celltrion Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 62. Sobi Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 63. 3SBIO Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 64. Changchun High Tech Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 65. Kanghong Pharma Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 66. Innovent Biologics Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 67. Gan&Lee Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 68. Tonghua Dongbao Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 69. United Laboratory Revenue Growth Rate in Biotech Drug Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart